Lupus (SLE): open trials in Czechia

2 open trials have a site in Czechia. Registry data; only the trial team decides who can take part.

NCT06711887
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
University Hospital Olomouc, Olomouc · Revmatologicky Ustav, Prague 2
Registry updated 2026-10-13
NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Fakultni Nemocnice Motol a Homolka, Prague · Revmatologicky Ustav, Prague 2
Registry updated 2026-07-14

This page is not medical advice. Talk to your doctor before contacting a trial.

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)